CTOs on the Move

HistoWiz

www.histowiz.com

 
HistoWiz is an innovative company dedicated to accelerating pathology-based research. HistoWiz provides fast, global access to digital whole-slide images, online collaboration tools, low-cost data management, and experimental pathology expertise. The web-based platform accelerates information exchange among medical scientists and research pathologists. HistoWiz`s mission is to fight cancer cooperatively instead of individually by connecting scientists and pathologists for online collaboration.
  • Number of Employees: 0-25
  • Annual Revenue: $0-1 Million
  • www.histowiz.com
  • Advanced Biotechnology Park 760 Parkside Avenue
    Brooklyn, NY USA 11226
  • Phone: 347.221.1020

Executives

Name Title Contact Details

Jobs

Chief Technology Officer

HistoWiz New York County, NY
The Chief Technology Officer (CTO) is responsible for overseeing all technical aspects of the company. The CTO will work closely with the CEO to develop the long-term tech vision of the company. The CTO is responsible for managing the entire code base and will be the primary developer for the ...

Similar Companies

R2 Technology

R2 Technology, Inc. is a Santa Clara, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Speedball Fitness

Speedball Fitness is a New York, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Asterias Biotherapeutics

Asterias Biotherapeutics is a leading biotechnology company in the emerging field of regenerative medicine. The company’s proprietary cell therapy programs are based on its immunotherapy and pluripotent stem cell platform technologies. Asterias is presently focused on advancing three clinical-stage programs which have the potential to address areas of very high unmet medical need in the fields of oncology and neurology.

AltPep

AltPep Corporation is a biomedical startup with a breakthrough approach for diagnosing and treating some of the world`s most intractable diseases: amyloid diseases. We are currently focusing on CNS disorders, in particular Alzheimer`s Disease (AD). We target and seek to neutralize the early toxic oligomers behind these amyloid diseases, which in the case of AD are due to aggregation of the Amyloid-beta peptide (Abeta).

Akston Biosciences